Pfizer (PFE) Aims $15 billion from COVID-19 vaccines sales in 2021
Pfizer (PFE) stock declined slightly despite a strong earnings report on Tuesday as investors focused on the company’s quarterly results. PFE stock performance year-to-date stands at -4.94%, while its performance over the last seven days is just below -6.22%. For the past month, the stock’s price index fell by -4.94%, and over the previous three-month […]
European Medicines Agency (EMA) to issue its decision on the BioNTech (NASDAQ: BNTX) and Pfizer (NYSE: PFE) vaccines
On December 21, the European Medicines Agency (EMA) expects to issue its decision on the BioNTech and Pfizer vaccines. After emergency approvals from the UK and the US earlier this month, the EU has come under growing pressure to authorize the vaccine. BioNTech and Pfizer had sent a conditional marketing permission proposal for their COVID-19 […]
